Cognitive Disorders

>

Latest News

From the relationship between glucose fluctuations and cognition in patients with type 1 diabetes to augmentation strategies for treatment-resistant depression, here are highlights from the week in Psychiatric Times.
The Week in Review: March 18-22

March 23rd 2024

From the relationship between glucose fluctuations and cognition in patients with type 1 diabetes to augmentation strategies for treatment-resistant depression, here are highlights from the week in Psychiatric Times.

diabetes
The Relationship Between Glucose Fluctuations and Cognition in Patients With Type 1 Diabetes

March 18th 2024

From mild cognitive impairment and serotonin system degeneration to an update on pimavanserin for negative symptoms of schizophrenia, here are highlights from the week in Psychiatric Times.
The Week in Review: March 11-15

March 16th 2024

“If we can show that serotonin loss over time is directly involved in the transition from mild cognitive impairment to Alzheimer disease, recently developed antidepressant medications may be an effective way to improve memory deficits and depressive symptoms and, thus, may be a powerful way forward to slow disease progression.”
Mild Cognitive Impairment and Serotonin System Degeneration

March 14th 2024

The screening tool includes multiple tests that assess memory, attention, executive function, reaction times, and motor function.
Digital Cognitive Assessment Platform Secures $15 Million Investment

March 7th 2024

Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.